CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 55 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,118 | +22.2% | 17,082 | +30.2% | 0.00% | – |
| Q4 2021 | $32,000 | -67.0% | 13,118 | -34.3% | 0.00% | – |
| Q3 2021 | $97,000 | +34.7% | 19,954 | -24.5% | 0.00% | -100.0% |
| Q2 2020 | $72,000 | +38.5% | 26,418 | +8.1% | 0.00% | 0.0% |
| Q1 2020 | $52,000 | -71.7% | 24,436 | -46.6% | 0.00% | -50.0% |
| Q1 2019 | $184,000 | -31.9% | 45,785 | -37.7% | 0.00% | -33.3% |
| Q4 2018 | $270,000 | -38.1% | 73,454 | +44.5% | 0.00% | -40.0% |
| Q3 2018 | $436,000 | +164.2% | 50,824 | +237.6% | 0.01% | +150.0% |
| Q2 2018 | $165,000 | +7.1% | 15,053 | +12.5% | 0.00% | 0.0% |
| Q1 2018 | $154,000 | – | 13,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,501,161 | 1.96% |
| TOWERVIEW LLC | 205,000 | $469,450 | 0.31% |
| Orbimed Advisors | 6,943,654 | $15,900,968 | 0.29% |
| CHI Advisors LLC | 200,000 | $458,000 | 0.14% |
| BVF INC/IL | 1,370,947 | $3,139,469 | 0.09% |
| SAMLYN CAPITAL, LLC | 2,105,930 | $4,822,580 | 0.08% |
| MYDA Advisors LLC | 100,000 | $229,000 | 0.07% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $22,900 | 0.06% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $146,040 | 0.06% |
| CORNERCAP INVESTMENT COUNSEL INC | 97,248 | $222,698 | 0.04% |